Fast-tracking psilocybin for refractory depression makes senseDecember 10, 2019DepressionMental Health
Efficacy of postvenetoclax therapy may depend on prior agent exposure in CLLDecember 10, 2019Rare Diseases
Bispecific CAR T-cells yield high response rate in relapsed/refractory myelomaDecember 7, 2019Multiple MyelomaOncologyImmuno-oncology
High complete response rate seen with novel CAR-T for myelomaDecember 7, 2019Multiple MyelomaImmuno-oncologyOncologyRare Diseases
Patient-reported outcomes support first-line pembrolizumab for NSCLCDecember 6, 2019Lung CancerImmuno-oncologyOncology
Intensive BP control reduced dementia but increased brain atrophy and hurt cognitionDecember 5, 2019NeurologyCardiologyMental Health
Understanding Principles of High Reliability Organizations Through the Eyes of VIONE, A Clinical Program to Improve Patient Safety by Deprescribing Potentially Inappropriate Medications and Reducing PolypharmacyDecember 5, 2019GeriatricsHealth Policy
Sequential CRT, immunotherapy nets high PFS in node-positive cervical cancerDecember 2, 2019OncologyImmuno-oncology
